Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors.
Gu P, Xue L, Zhao C, Li W, Jiang Z, Liu A, Li T, Liu L, Decker M, Cheng X, Yang W, Tang R.
Gu P, et al. Among authors: li t, li w.
Front Oncol. 2022 May 13;12:885186. doi: 10.3389/fonc.2022.885186. eCollection 2022.
Front Oncol. 2022.
PMID: 35646698
Free PMC article.